Why UK Patients Are Comparing Wegovy and Mounjaro Prices
Is Wegovy Going Up in Price Compared to Mounjaro in 2026?
Market dynamics around prescription weight management medications continue evolving, but EverydayMeds maintains stable pricing for both Wegovy and Mounjaro. Unlike pharmacies adjusting costs frequently, our Wegovy pricing structure starts at £79.99 for the 0.25mg starter dose, progressing through to £209.99 for the 2.4mg maintenance dose. Mounjaro follows a different pricing tier reflecting its dual GIP and GLP-1 receptor mechanism compared to Wegovy's single GLP-1 approach.
The question isn't whether Wegovy prices are rising elsewhere, but rather which medication suits your clinical needs and budget long-term. Wegovy requires five dose escalations over 16 weeks, whilst Mounjaro uses six doses escalating to 15mg maximum. Both are prescription-only medicines requiring clinical assessment, but their different mechanisms may influence prescriber choice. EverydayMeds stocks both options, allowing your prescriber flexibility without forcing you to source from multiple pharmacies.
Wegovy vs Mounjaro Pricing Structure and Bundle Savings
Our transparent pricing eliminates guesswork around whether Wegovy costs are increasing unpredictably. The Intro Duo bundle (0.25mg and 0.5mg) costs £169.99, covering your first 8 weeks with discount codes applied at checkout. For maintenance patients, the Ultimate Stability Trio provides three months of 2.4mg supply at £649.99. New customers use code FIRST40, whilst returning customers apply DOSE25 during checkout to access these prices.
Mounjaro's pricing reflects its different dosing schedule and dual-hormone mechanism, targeting both GIP and GLP-1 receptors rather than GLP-1 alone like Wegovy. Rather than comparing whether Wegovy prices are going up relative to Mounjaro, consider the total cost of treatment including prescriber fees, delivery, and storage requirements. Both medications must be stored in refrigeration at 2-8°C, but Wegovy tolerates 6 weeks at room temperature versus Mounjaro's 21-day limit—important for travel or supply chain delays.
Clinical Evidence Behind Wegovy vs Mounjaro Price Positioning
The STEP clinical trial programme demonstrated that patients taking Wegovy alongside diet and exercise achieved approximately 15% average weight loss at 68 weeks, compared to 2.4% with placebo (Wilding et al., NEJM, 2021). This evidence base supports Wegovy's pricing structure as it reflects extensive clinical validation across multiple patient populations. The SELECT trial also showed 20% reduction in major cardiovascular events, adding value beyond weight management alone.
Mounjaro's clinical profile stems from the SURMOUNT trials, showing its dual GIP and GLP-1 mechanism may offer different benefits compared to Wegovy's single-pathway approach. When considering whether Wegovy prices are going up relative to Mounjaro, remember that both medications work differently and may suit different patient profiles. Your prescriber can help determine which mechanism aligns with your medical history and weight management goals, regardless of minor price variations.
How Wegovy's GLP-1 Mechanism Justifies Pricing Stability
Wegovy works by mimicking GLP-1, a natural hormone that promotes feelings of fullness after eating smaller portions. This mechanism reduces appetite through brain appetite centres, potentially decreasing food cravings between meals. Unlike rapid-acting appetite suppressants, Wegovy's once-weekly injection provides sustained appetite regulation over seven days. The FlexTouch pen delivery system ensures accurate dosing whilst remaining simple for patients to self-administer. When questioning whether Wegovy prices are going up, consider that this established mechanism has extensive safety data and proven efficacy in long-term weight management alongside reduced-calorie diet and increased physical activity.
Ordering Process: Avoiding Price Uncertainty with Direct Access
Rather than worrying whether Wegovy costs are increasing elsewhere, secure your supply through EverydayMeds' streamlined process starting with a 3-minute online clinical assessment. Our prescribers review applications within 3 working days (express 24-hour service available), ensuring you know exactly when your medication will arrive. Once approved, next-day delivery uses cold-chain temperature control protecting medication integrity regardless of weather conditions. This process eliminates price shopping between pharmacies whilst ensuring clinical safety through proper prescriber oversight. GPhC registration #9012878 ensures you're accessing genuine Novo Nordisk Wegovy through legitimate UK pharmaceutical channels.
Storage Requirements and Practical Cost Considerations
Wegovy's storage advantage becomes financially relevant when considering whether prices are going up due to supply chain pressures. The 6-week room temperature tolerance (below 30°C) means less waste if refrigeration fails temporarily, unlike medications requiring constant cold storage. Each FlexTouch pen contains four doses, and the dose escalation schedule from 0.25mg to 2.4mg occurs over 16 weeks, requiring careful planning to avoid gaps. Store unopened pens in your refrigerator at 2-8°C, removing only when ready to use. This storage flexibility adds value beyond the listed price, particularly during travel or if your regular pharmacy experiences supply shortages affecting pricing stability.
UK Market Dynamics: Why Wegovy and Mounjaro Pricing Remains Stable
Instead of asking whether Wegovy costs are going up due to market pressures, understand that both medications serve growing demand for clinically-proven weight management options. NICE guidance TA875 recommends Wegovy alongside specialist weight management support, creating predictable demand patterns. EverydayMeds' dual-stock approach means we're not dependent on single-supplier relationships that might force sudden price increases. Our GPhC-registered status ensures compliance with UK pharmaceutical regulations governing pricing transparency and patient access.
Both Wegovy and Mounjaro represent significant pharmaceutical investments in obesity medicine, with pricing reflecting research, manufacturing, and regulatory costs rather than artificial market inflation. When considering whether Wegovy prices are going up compared to alternatives, remember that switching between GLP-1 medications requires medical supervision and may restart side effect adaptation periods. Consistent supplier relationships often prove more cost-effective than chasing marginal price differences between pharmacies offering unknown service standards.
Making Your Choice: Beyond Price Considerations
Rather than focusing solely on whether Wegovy costs are increasing relative to Mounjaro, discuss with your prescriber which mechanism suits your medical profile, lifestyle, and long-term goals. Both medications require commitment to reduced-calorie diet and increased physical activity, with weight regain possible if discontinued. EverydayMeds stocks both options, eliminating the need to change pharmacies if your prescriber recommends switching medications. Apply discount codes FIRST40 (new customers) or DOSE25 (returning customers) at checkout to access our published pricing structure. Visit https://everydaymeds.co.uk/collections/weight-loss to begin your clinical assessment and secure stable pricing for whichever medication your prescriber recommends. Both Wegovy and Mounjaro are available through our temperature-controlled delivery network, ensuring medication integrity regardless of market supply pressures affecting other pharmacies.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
